OncologyPaclitaxel October 14, 2017 Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of PaclitaxelSaladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses. The… admin Love0
OncologyPaclitaxel October 19, 2016 Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated NeuropathySaladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced… admin Love0
OncologyPaclitaxel June 9, 2015 Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO MeetingLarge Study Confirms the Benefit to Patients of Advanced Dosing Method for Saladax Biomedical, Inc.… admin Love0